Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Introduction: Pre-eclampsia is a multifactorial syndrome which occurs in hypertension and proteinuria in pregnant women over 20 weeks gestation. It is the leading cause of maternal complications such as pulmonary edema, which occurs in about 3% of severe preeclamptic having as one of the causes volume overload. Anesthetic procedures are frequent in this population, with replacement with crystalloid of the duct during cesarean section under spinal anesthesia for combat hypotension and hypovolemia manifested by oliguria. However, as water therapy have antagonistic effects on cardiopulmonary and renal systems is no doubt as to the benefits compared to conventional or restrictive pattern of fluid therapy on renal function. Objective: To compare the renal function of patients with severe preeclampsia who received restrictive fluid therapy during caesarean section, as well as evaluating the use of cystatin C and Neutrophil gelatinase-associated lipocalin (NGAL) as a predictor of renal damage in this population. Hypothesis: Intraoperative fluid restriction did not influence renal function of patients with severe preeclampsia undergoing cesarean section under spinal anesthesia.
Preeclampsia (PE) is the leading cause of morbidity and mortality worldwide during pregnancy. Fluid therapy for PE women during cesarean section is a controversial issue among medical specialists.
The replacement with crystalloid fluids tool is traditionally used by anesthesiologists during cesarean section under spinal anesthesia for combat hypotension and hypovolemia manifested by oliguria. However, as crystalloid infusion has antagonistic effects on cardiopulmonary and renal systems, there is controversy regarding benefits over conventional and restrictive fluid therapy. Therefore, due to cardiovascular changes in severe PE, restrictive fluid therapy could possibly be beneficial, avoiding complications such as acute pulmonary edema.
Currently, volume replacement during cesarean section in these patients is performed with volumes of about 1500 ml of crystalloid to decrease the chance of developing kidney injury or aggravating previous injury. However, it is not known in the literature whether the renal lesions that appear after birth in patients with PE are just due to the course of the disease itself or can be modified by fluid restriction during the conduct of anesthesia cesarean.
Moreover, intraoperative fluid restriction (250 ml crystalloid) appears as an alternative to handling the patient with PEG, as already safely used in cardiac patients, such as patients with mitral valve stenosis. The security of fluid restriction in patients with PE comes from the fact that pre-eclamptic suffer fewer episodes of hypotension during cesarean section under spinal anesthesia, requiring less fluid input for this purpose. In addition, the pathophysiology of this disease points to a relative hypovolemia, once the delivery performed, with removal of the placenta, fluids kidnapped in excess to third space (tissue edema) will be redirected to the intravascular compartment, restoring homeostasis.
Cystatin C and NGAL (Neutrophil gelatinase-associated lipocalin) arise as valid tools to predict the degree of renal injury. These molecules arise before the onset of renal injury, providing diagnostic and therapeutic actions that can reduce morbidity and mortality related to kidney failure, since some studies have shown that women in first pregnancy with PE are more likely to develop chronic kidney disease that pregnant women without PE.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Liberal Fluid therapy | No Intervention | The liberal group will receive 1500 mL of crystalloid solution during the cesarean section. This is the non-intervention arm once that 1500 ml of crystalloid is the amount usually used during caesarean. | |
| Restrictive Fluid Therapy | Active Comparator | The restrictive group will receive 250 mL of crystalloid solution during cesarean section. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Restrictive Fluid Therapy | Other | The intervention in this randomized clinical trial is fluid restriction during cesarean section. The restricted group will receive 250 mL of crystalloid during surgery. |
| Measure | Description | Time Frame |
|---|---|---|
| Renal Function in Severe Preeclampsia With Restrictive Fluid Therapy | Renal function evaluated through creatinine levels in three moments: preoperative, first and second postoperative days. | preoperative, first and second day postoperative |
| Postoperative Renal Dysfunction Evaluated by the Acute Kidney Injury Network (AKIN) Index | Renal dysfunction was stratified by the Acute Kidney Injury Network (AKIN) index in three stages, in terms of creatinine increase from baseline: stage 1 included an interval of 150-200%, stage 2 200%-300%, and stage 3 more than 300% or hemodialysis | Postoperative renal dysfunction |
| Measure | Description | Time Frame |
|---|---|---|
| Neutrophil Gelatinase-associated Lipocalin (NGAL) as New Marker of Renal Injury in Preeclampsia | Evaluate new marker of renal injury (NGAL) in the specific population of patients with severe preeclampsia, comparing the values of first and second postoperative days to baseline. | preoperative, first and second day postoperative |
| Measure | Description | Time Frame |
|---|---|---|
| Urine Output During Cesarean Section in Severe Pre-eclampsia | Urine output during cesarean section in severe pre-eclampsia under two different regimes of hydration (restrictive and liberal) | urine output during cesarean section (an average of 60 minutes) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wallace A Da Silva, MD | University of Sao Paulo | Principal Investigator |
| Fernando Bliacheriene, PHD | University of Sao Paulo | Study Chair |
| Maria José C Carmona, PHD | University of Sao Paulo | Study Director |
| Carlo Victor A Varela, MD | University of Sao Paulo | Study Chair |
| Paula C Scherer, MD | University of Sao Paulo | Study Chair |
| Marcelo Luis A Torres, PHD | University of Sao Paulo | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital das Clínicas da Faculdade de Medicina da USP | São Paulo | São Paulo | 01246903 | Brazil |
Not provided
Not provided
We calculated the total sample size from a pilot study. Assuming a power of 80% and 95% confidence, the sample necessary to conduct the study was 21 patients in each group of interest. As we considered 10% as maximum margin of loss during follow-up, there were 23 patients enrolled in each group.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Liberal Fluid Therapy | The liberal group will receive 1500 mL of crystalloid solution during the cesarean section. This is the non-intervention arm once that 1500 ml of crystalloid is the amount usually used during caesarean. |
| FG001 | Restrictive Fluid Therapy | The restrictive group will receive 250 mL of crystalloid solution during cesarean section. Restrictive Fluid Therapy: The intervention in this randomized clinical trial is fluid restriction during cesarean section. The restricted group will receive 250 mL of crystalloid during surgery. |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Liberal Fluid Therapy | The liberal group will receive 1500 mL of crystalloid solution during the cesarean section. This is the non-intervention arm once that 1500 ml of crystalloid is the amount usually used during caesarean. |
| BG001 | Restrictive Fluid Therapy |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Renal Function in Severe Preeclampsia With Restrictive Fluid Therapy | Renal function evaluated through creatinine levels in three moments: preoperative, first and second postoperative days. | Were included in the analysis the patients who violated the protocol and lost follow-up (intention to treat analysis) | Posted | Median | Inter-Quartile Range | mg/dl | preoperative, first and second day postoperative |
|
Possible adverse event were observed during the first and second post-operative days
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Liberal Fluid Therapy | The liberal group will receive 1500 mL of crystalloid solution during the cesarean section. This is the non-intervention arm once that 1500 ml of crystalloid is the amount usually used during caesarean. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| M.D. Wallace Andrino da Silva | Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo | +551126616787 | wallaceandrino@yahoo.com.br |
Not provided
| ID | Term |
|---|---|
| D011225 | Pre-Eclampsia |
| D058186 | Acute Kidney Injury |
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Cystatin C as New Marker of Renal Injury in Preeclampsia |
Evaluate new marker of renal injury (Cystatin C) in the specific population of patients with severe preeclampsia, comparing the values of first and second postoperative days to baseline. |
| preoperative, first and second day postoperative |
| Proteinuria in Severe Pre-eclampsia Submitted to Cesarean Section Under Different Regimes of Hydration | Proteinuria in severe pre-eclampsia submitted to cesarean section under different regimes of hydration. Analyses in pre-operative and post-operative period. | Proteinuria in severe pre-eclampsia in in pre-operative and post-operative period |
| Platelets in Restrictive Fluid Management of Severe Preeclampsia | Compare platelets count in the restrictive and liberal groups during the first and second post-operative days. | preoperative, first and second day postoperative |
| International Normalized Ratio (INR) of Prothrombin Time (PT) in Restrictive Fluid Management of Severe Preeclampsia During Cesarean Section | Compare International Normalized Ratio (INR) of Prothrombin Time (PT) in the restrictive and liberal groups in preoperative, first and second day postoperative. PT is expressed in seconds and the entered values represented the INR of PT among study participants and a control population. | preoperative, first and second day postoperative |
| Activated Partial Thromboplastin Time in Restrictive Fluid Management of Severe Preeclampsia During Cesarean Section | Compare activated partial thromboplastin time (APPT) and relation with control (R) in the restrictive and liberal groups. APPT is a laboratory test that evaluates the efficiency of the intrinsic pathway of coagulation. The unit of measure is seconds and the results are presented as relation (R) with control. | preoperative, first and second day postoperative |
| 12933418 | Background | Aya AGM, Mangin R, Vialles N, Ferrer JM, Robert C, Ripart J, de La Coussaye JE. Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison. Anesth Analg. 2003 Sep;97(3):867-872. doi: 10.1213/01.ANE.0000073610.23885.F2. |
| 15635522 | Background | Pan PH, D'Angelo R. Anesthetic and analgesic management of mitral stenosis during pregnancy. Reg Anesth Pain Med. 2004 Nov-Dec;29(6):610-5. doi: 10.1016/j.rapm.2004.09.006. No abstract available. |
| 18431115 | Background | Dyer RA, Piercy JL, Reed AR, Lombard CJ, Schoeman LK, James MF. Hemodynamic changes associated with spinal anesthesia for cesarean delivery in severe preeclampsia. Anesthesiology. 2008 May;108(5):802-11. doi: 10.1097/01.anes.0000311153.84687.c7. |
| 2603896 | Background | Mabie WC, Ratts TE, Sibai BM. The central hemodynamics of severe preeclampsia. Am J Obstet Gynecol. 1989 Dec;161(6 Pt 1):1443-8. doi: 10.1016/0002-9378(89)90901-0. |
| 22420683 | Background | Dennis AT, Solnordal CB. Acute pulmonary oedema in pregnant women. Anaesthesia. 2012 Jun;67(6):646-59. doi: 10.1111/j.1365-2044.2012.07055.x. Epub 2012 Mar 15. |
| 20478690 | Background | Aya AG, Vialles N, Ripart J. [Anesthesia and preeclampsia]. Ann Fr Anesth Reanim. 2010 May;29(5):e141-7. doi: 10.1016/j.annfar.2010.03.014. Epub 2010 May 15. French. |
| 21707441 | Background | Urbschat A, Obermuller N, Haferkamp A. Biomarkers of kidney injury. Biomarkers. 2011 Jul;16 Suppl 1:S22-30. doi: 10.3109/1354750X.2011.587129. |
| 18716297 | Background | Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008 Aug 21;359(8):800-9. doi: 10.1056/NEJMoa0706790. |
| 18925531 | Background | Xin C, Yulong X, Yu C, Changchun C, Feng Z, Xinwei M. Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Ren Fail. 2008;30(9):904-13. doi: 10.1080/08860220802359089. |
| 21765189 | Background | Martensson J, Martling CR, Oldner A, Bell M. Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients. Nephrol Dial Transplant. 2012 Feb;27(2):576-81. doi: 10.1093/ndt/gfr358. Epub 2011 Sep 12. |
| 17331245 | Background | Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. doi: 10.1186/cc5713. |
| 32725073 | Derived | Silva WAD, Varela CVA, Pinheiro AM, Scherer PC, Francisco RPV, Torres MLA, Carmona MJC, Bliacheriene F, Andrade LC, Pelosi P, Malbouisson LMS. Restrictive versus Liberal Fluid Therapy for Post-Cesarean Acute Kidney Injury in Severe Preeclampsia: a Pilot Randomized Clinical Trial. Clinics (Sao Paulo). 2020;75:e1797. doi: 10.6061/clinics/2020/e1797. Epub 2020 Jul 22. |
The restrictive group will receive 250 mL of crystalloid solution during cesarean section. Restrictive Fluid Therapy: The intervention in this randomized clinical trial is fluid restriction during cesarean section. The restricted group will receive 250 mL of crystalloid during surgery. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Gender | Count of Participants | Participants |
|
| Gestational age (weeks) | Median | Inter-Quartile Range | weeks |
|
| Body mass index (kg/m2) | Mean | Standard Deviation | kg/m2 |
|
| Twin pregnancy | Number | participants |
|
| Chronic hypertension | Number | participants |
|
| Previous preeclampsia | Number | participants |
|
| Diabetes Mellitus | Number | participants |
|
| Systolic blood pressure (mmHg) | Mean | Standard Deviation | mmHg |
|
| Diastolic blood pressure (mmHg) | Mean | Standard Deviation | mmHg |
|
The restrictive group will receive 250 mL of crystalloid solution during cesarean section.
Restrictive Fluid Therapy: The intervention in this randomized clinical trial is fluid restriction during cesarean section. The restricted group will receive 250 mL of crystalloid during surgery.
|
|
|
| Secondary | Neutrophil Gelatinase-associated Lipocalin (NGAL) as New Marker of Renal Injury in Preeclampsia | Evaluate new marker of renal injury (NGAL) in the specific population of patients with severe preeclampsia, comparing the values of first and second postoperative days to baseline. | Posted | Median | Inter-Quartile Range | mg/L | preoperative, first and second day postoperative |
|
|
|
|
| Secondary | Cystatin C as New Marker of Renal Injury in Preeclampsia | Evaluate new marker of renal injury (Cystatin C) in the specific population of patients with severe preeclampsia, comparing the values of first and second postoperative days to baseline. | Posted | Mean | Standard Deviation | mg/L | preoperative, first and second day postoperative |
|
|
|
|
| Secondary | Proteinuria in Severe Pre-eclampsia Submitted to Cesarean Section Under Different Regimes of Hydration | Proteinuria in severe pre-eclampsia submitted to cesarean section under different regimes of hydration. Analyses in pre-operative and post-operative period. | Posted | Median | Inter-Quartile Range | g/dl | Proteinuria in severe pre-eclampsia in in pre-operative and post-operative period |
|
|
|
|
| Secondary | Platelets in Restrictive Fluid Management of Severe Preeclampsia | Compare platelets count in the restrictive and liberal groups during the first and second post-operative days. | Posted | Mean | Standard Deviation | thrombocytes/mm3 | preoperative, first and second day postoperative |
|
|
|
|
| Secondary | International Normalized Ratio (INR) of Prothrombin Time (PT) in Restrictive Fluid Management of Severe Preeclampsia During Cesarean Section | Compare International Normalized Ratio (INR) of Prothrombin Time (PT) in the restrictive and liberal groups in preoperative, first and second day postoperative. PT is expressed in seconds and the entered values represented the INR of PT among study participants and a control population. | The values are expressed in seconds and presented as a ration (INR) with control patients. | Posted | Median | Inter-Quartile Range | ratio | preoperative, first and second day postoperative |
|
|
|
|
| Other Pre-specified | Urine Output During Cesarean Section in Severe Pre-eclampsia | Urine output during cesarean section in severe pre-eclampsia under two different regimes of hydration (restrictive and liberal) | Posted | Median | Inter-Quartile Range | ml/h | urine output during cesarean section (an average of 60 minutes) |
|
|
|
|
| Secondary | Activated Partial Thromboplastin Time in Restrictive Fluid Management of Severe Preeclampsia During Cesarean Section | Compare activated partial thromboplastin time (APPT) and relation with control (R) in the restrictive and liberal groups. APPT is a laboratory test that evaluates the efficiency of the intrinsic pathway of coagulation. The unit of measure is seconds and the results are presented as relation (R) with control. | The values are expressed in seconds and presented as a ration (R) with control patients. | Posted | Mean | Standard Deviation | ratio | preoperative, first and second day postoperative |
|
|
|
|
| Primary | Postoperative Renal Dysfunction Evaluated by the Acute Kidney Injury Network (AKIN) Index | Renal dysfunction was stratified by the Acute Kidney Injury Network (AKIN) index in three stages, in terms of creatinine increase from baseline: stage 1 included an interval of 150-200%, stage 2 200%-300%, and stage 3 more than 300% or hemodialysis | Posted | Number | participants | Postoperative renal dysfunction |
|
|
|
|
| 0 |
| 21 |
| 0 |
| 21 |
| EG001 | Restrictive Fluid Therapy | The restrictive group will receive 250 mL of crystalloid solution during cesarean section. Restrictive Fluid Therapy: The intervention in this randomized clinical trial is fluid restriction during cesarean section. The restricted group will receive 250 mL of crystalloid during surgery. | 0 | 21 | 0 | 21 |
Not provided
Not provided
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| NGAL 2nd post-operative day |
|
| Cyst C 2nd postoperative day |
|
| Proteinuria 2nd post-operative day |
|
| Platelets 2nd postoperative day |
|
| PT/INR seconde post-operative day |
|
| APPT/R 2nd post-operative day |
|
| AKIN stage III |
|